 Robin Shandas
Concepts (370)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Models, Cardiovascular | 32 | 2016 | 179 | 3.970 |
Why?
| | Pulmonary Artery | 26 | 2016 | 1055 | 3.520 |
Why?
| | Hypertension, Pulmonary | 24 | 2017 | 1784 | 2.590 |
Why?
| | Ultrasonography | 15 | 2017 | 714 | 2.490 |
Why?
| | Rheology | 9 | 2018 | 86 | 2.160 |
Why?
| | Blood Flow Velocity | 24 | 2018 | 327 | 2.030 |
Why?
| | Microbubbles | 12 | 2013 | 38 | 2.020 |
Why?
| | Pulmonary Circulation | 10 | 2017 | 423 | 1.950 |
Why?
| | Image Interpretation, Computer-Assisted | 9 | 2016 | 220 | 1.550 |
Why?
| | Vascular Resistance | 8 | 2017 | 356 | 1.400 |
Why?
| | Hemorheology | 9 | 2005 | 20 | 1.180 |
Why?
| | Carotid Arteries | 5 | 2017 | 184 | 1.150 |
Why?
| | Contrast Media | 8 | 2017 | 373 | 1.080 |
Why?
| | Ultrasonography, Doppler | 4 | 2018 | 104 | 1.000 |
Why?
| | Hemodynamics | 9 | 2017 | 1002 | 0.960 |
Why?
| | Algorithms | 8 | 2016 | 1522 | 0.930 |
Why?
| | Blood Pressure | 14 | 2016 | 1656 | 0.910 |
Why?
| | Surgical Mesh | 2 | 2013 | 41 | 0.910 |
Why?
| | Fontan Procedure | 7 | 2009 | 154 | 0.880 |
Why?
| | Computer Simulation | 18 | 2018 | 913 | 0.840 |
Why?
| | Materials Testing | 6 | 2019 | 359 | 0.800 |
Why?
| | Echocardiography, Doppler | 5 | 2006 | 94 | 0.790 |
Why?
| | Polymers | 7 | 2018 | 482 | 0.790 |
Why?
| | Heart Ventricles | 5 | 2016 | 725 | 0.720 |
Why?
| | Arteries | 6 | 2013 | 250 | 0.720 |
Why?
| | Stress, Mechanical | 14 | 2018 | 441 | 0.700 |
Why?
| | Models, Biological | 7 | 2011 | 1701 | 0.680 |
Why?
| | Laparoscopy | 2 | 2013 | 417 | 0.670 |
Why?
| | Carotid Artery, Common | 1 | 2018 | 30 | 0.640 |
Why?
| | Image Enhancement | 3 | 2009 | 181 | 0.630 |
Why?
| | Blood Pressure Determination | 3 | 2008 | 133 | 0.610 |
Why?
| | Image Processing, Computer-Assisted | 5 | 2017 | 709 | 0.610 |
Why?
| | Models, Theoretical | 7 | 2013 | 554 | 0.590 |
Why?
| | Transducers | 2 | 2009 | 27 | 0.580 |
Why?
| | Patient-Specific Modeling | 1 | 2016 | 37 | 0.580 |
Why?
| | Imaging, Three-Dimensional | 5 | 2013 | 500 | 0.560 |
Why?
| | Heart Defects, Congenital | 5 | 2007 | 700 | 0.550 |
Why?
| | Compliance | 4 | 2011 | 44 | 0.540 |
Why?
| | Ultrasonics | 3 | 2013 | 53 | 0.530 |
Why?
| | Elasticity | 10 | 2015 | 192 | 0.500 |
Why?
| | Vascular Endothelial Growth Factor A | 5 | 2022 | 523 | 0.490 |
Why?
| | Elastic Modulus | 3 | 2013 | 118 | 0.480 |
Why?
| | Hernia, Ventral | 1 | 2013 | 19 | 0.470 |
Why?
| | Polyesters | 1 | 2013 | 65 | 0.460 |
Why?
| | Reproducibility of Results | 10 | 2018 | 2856 | 0.450 |
Why?
| | Ventricular Function, Right | 4 | 2017 | 257 | 0.450 |
Why?
| | Ventricular Dysfunction, Right | 3 | 2015 | 232 | 0.440 |
Why?
| | Biocompatible Materials | 3 | 2013 | 378 | 0.440 |
Why?
| | Magnetic Resonance Imaging | 4 | 2017 | 3169 | 0.430 |
Why?
| | Vasodilator Agents | 2 | 2011 | 328 | 0.420 |
Why?
| | Elastin | 2 | 2011 | 77 | 0.420 |
Why?
| | Heart-Assist Devices | 2 | 2009 | 485 | 0.420 |
Why?
| | Equipment Failure Analysis | 5 | 2013 | 139 | 0.410 |
Why?
| | Models, Anatomic | 3 | 2018 | 94 | 0.400 |
Why?
| | Cattle | 11 | 2017 | 974 | 0.400 |
Why?
| | Heart Bypass, Right | 3 | 2006 | 15 | 0.400 |
Why?
| | Myocardial Perfusion Imaging | 1 | 2011 | 41 | 0.390 |
Why?
| | Vascular Stiffness | 6 | 2017 | 425 | 0.390 |
Why?
| | Ventricular Function, Left | 3 | 2004 | 468 | 0.390 |
Why?
| | MicroRNAs | 1 | 2017 | 633 | 0.380 |
Why?
| | Ultrasonography, Doppler, Pulsed | 1 | 2010 | 6 | 0.380 |
Why?
| | Shear Strength | 5 | 2017 | 55 | 0.360 |
Why?
| | Uncertainty | 1 | 2010 | 100 | 0.350 |
Why?
| | Micro-Electrical-Mechanical Systems | 1 | 2009 | 5 | 0.350 |
Why?
| | Numerical Analysis, Computer-Assisted | 4 | 2004 | 17 | 0.350 |
Why?
| | Animals | 31 | 2022 | 33152 | 0.340 |
Why?
| | Miniaturization | 2 | 2009 | 24 | 0.330 |
Why?
| | Child | 19 | 2018 | 19033 | 0.320 |
Why?
| | Humans | 53 | 2018 | 118270 | 0.310 |
Why?
| | Laser-Doppler Flowmetry | 2 | 2004 | 33 | 0.310 |
Why?
| | Tissue Scaffolds | 3 | 2019 | 184 | 0.310 |
Why?
| | Phantoms, Imaging | 4 | 2014 | 139 | 0.300 |
Why?
| | Aortic Valve | 2 | 2009 | 402 | 0.300 |
Why?
| | Myocytes, Smooth Muscle | 3 | 2017 | 236 | 0.300 |
Why?
| | Biomarkers | 1 | 2017 | 3568 | 0.290 |
Why?
| | Heart Septal Defects | 1 | 2006 | 10 | 0.290 |
Why?
| | Gels | 2 | 2018 | 72 | 0.280 |
Why?
| | Vasomotor System | 1 | 2006 | 47 | 0.280 |
Why?
| | Pulsatile Flow | 6 | 2012 | 54 | 0.280 |
Why?
| | Lung | 4 | 2013 | 3623 | 0.280 |
Why?
| | Child, Preschool | 15 | 2017 | 9448 | 0.280 |
Why?
| | Male | 24 | 2018 | 57479 | 0.270 |
Why?
| | Sensitivity and Specificity | 7 | 2016 | 1787 | 0.270 |
Why?
| | In Vitro Techniques | 6 | 2012 | 1082 | 0.270 |
Why?
| | Magnetic Resonance Imaging, Cine | 2 | 2017 | 154 | 0.270 |
Why?
| | Tissue Engineering | 3 | 2019 | 363 | 0.260 |
Why?
| | Reference Values | 4 | 2018 | 770 | 0.260 |
Why?
| | Hypoxia | 1 | 2011 | 957 | 0.260 |
Why?
| | Myocytes, Cardiac | 3 | 2019 | 470 | 0.260 |
Why?
| | Scattering, Radiation | 4 | 2006 | 93 | 0.250 |
Why?
| | Female | 23 | 2018 | 61269 | 0.250 |
Why?
| | Cardiovascular System | 2 | 2006 | 127 | 0.250 |
Why?
| | Linear Models | 3 | 2007 | 817 | 0.240 |
Why?
| | Diagnosis, Computer-Assisted | 2 | 2005 | 66 | 0.240 |
Why?
| | Rats, Sprague-Dawley | 6 | 2019 | 2434 | 0.240 |
Why?
| | Aorta | 2 | 2005 | 364 | 0.240 |
Why?
| | Stroke Volume | 2 | 2017 | 513 | 0.240 |
Why?
| | Connective Tissue | 1 | 2004 | 37 | 0.240 |
Why?
| | Ventricular Function | 1 | 2004 | 60 | 0.240 |
Why?
| | Physical Stimulation | 1 | 2004 | 79 | 0.230 |
Why?
| | Energy Transfer | 1 | 2004 | 52 | 0.230 |
Why?
| | Crystallization | 1 | 2004 | 146 | 0.230 |
Why?
| | Rats | 7 | 2019 | 5339 | 0.230 |
Why?
| | Animals, Newborn | 5 | 2016 | 804 | 0.230 |
Why?
| | Radiographic Image Interpretation, Computer-Assisted | 1 | 2004 | 109 | 0.220 |
Why?
| | Echocardiography | 2 | 2005 | 556 | 0.220 |
Why?
| | Nanotechnology | 1 | 2004 | 120 | 0.220 |
Why?
| | Ventricular Dysfunction, Left | 1 | 2006 | 374 | 0.210 |
Why?
| | Aortic Coarctation | 1 | 2003 | 57 | 0.210 |
Why?
| | Biomechanical Phenomena | 4 | 2013 | 683 | 0.210 |
Why?
| | Hydrogels | 3 | 2022 | 582 | 0.210 |
Why?
| | Coronary Angiography | 1 | 2004 | 311 | 0.200 |
Why?
| | Neovascularization, Physiologic | 2 | 2020 | 181 | 0.200 |
Why?
| | Acrylamides | 2 | 2018 | 42 | 0.190 |
Why?
| | Muscle, Smooth, Vascular | 2 | 2017 | 455 | 0.190 |
Why?
| | Cardiac Catheterization | 4 | 2015 | 541 | 0.190 |
Why?
| | Case-Control Studies | 5 | 2017 | 3156 | 0.190 |
Why?
| | Adolescent | 12 | 2017 | 18364 | 0.180 |
Why?
| | Delayed-Action Preparations | 2 | 2018 | 161 | 0.180 |
Why?
| | Regional Blood Flow | 6 | 2013 | 417 | 0.180 |
Why?
| | Equipment Design | 4 | 2014 | 518 | 0.180 |
Why?
| | Infant | 8 | 2015 | 8254 | 0.180 |
Why?
| | Vena Cava, Inferior | 3 | 2006 | 55 | 0.180 |
Why?
| | Hypertension | 1 | 2008 | 1199 | 0.170 |
Why?
| | Temperature | 3 | 2014 | 621 | 0.170 |
Why?
| | Biomimetic Materials | 2 | 2017 | 66 | 0.170 |
Why?
| | Models, Statistical | 3 | 2015 | 633 | 0.170 |
Why?
| | Ultrasonography, Doppler, Color | 2 | 2010 | 35 | 0.170 |
Why?
| | Particle Size | 4 | 2013 | 345 | 0.170 |
Why?
| | Echocardiography, Three-Dimensional | 1 | 1999 | 53 | 0.160 |
Why?
| | Angiogenesis Inducing Agents | 1 | 2018 | 23 | 0.160 |
Why?
| | Gold | 1 | 2019 | 102 | 0.160 |
Why?
| | Metal Nanoparticles | 1 | 2019 | 73 | 0.160 |
Why?
| | Sulfones | 1 | 2018 | 98 | 0.160 |
Why?
| | Pulmonary Wedge Pressure | 2 | 2009 | 65 | 0.160 |
Why?
| | Myocardial Infarction | 2 | 2022 | 967 | 0.150 |
Why?
| | Heart Valve Diseases | 1 | 1999 | 136 | 0.150 |
Why?
| | Nanotubes, Carbon | 1 | 2017 | 44 | 0.150 |
Why?
| | Computer-Aided Design | 2 | 2009 | 42 | 0.150 |
Why?
| | Finite Element Analysis | 3 | 2007 | 70 | 0.140 |
Why?
| | Bronchoscopy | 1 | 2018 | 246 | 0.140 |
Why?
| | Cardiac Output | 1 | 2016 | 147 | 0.140 |
Why?
| | Laminin | 1 | 2016 | 68 | 0.140 |
Why?
| | Disease Models, Animal | 3 | 2011 | 3676 | 0.140 |
Why?
| | Biomimetics | 1 | 2016 | 38 | 0.140 |
Why?
| | Echinococcosis, Pulmonary | 1 | 2015 | 6 | 0.140 |
Why?
| | Endothelial Cells | 2 | 2012 | 717 | 0.130 |
Why?
| | Embryonic Stem Cells | 1 | 2016 | 114 | 0.130 |
Why?
| | Drug Carriers | 2 | 2013 | 119 | 0.130 |
Why?
| | Acoustics | 2 | 2006 | 54 | 0.130 |
Why?
| | Arterial Pressure | 1 | 2015 | 99 | 0.130 |
Why?
| | Pilot Projects | 2 | 2011 | 1405 | 0.130 |
Why?
| | Serum Albumin, Bovine | 1 | 2014 | 67 | 0.120 |
Why?
| | Fibroblasts | 1 | 2019 | 835 | 0.120 |
Why?
| | Severity of Illness Index | 4 | 2017 | 2659 | 0.120 |
Why?
| | Familial Primary Pulmonary Hypertension | 2 | 2013 | 191 | 0.120 |
Why?
| | Bronchi | 1 | 2015 | 241 | 0.120 |
Why?
| | Magnetic Resonance Angiography | 1 | 2016 | 210 | 0.120 |
Why?
| | Lysine | 1 | 2016 | 247 | 0.120 |
Why?
| | Feasibility Studies | 4 | 2015 | 746 | 0.120 |
Why?
| | Airway Extubation | 1 | 2014 | 45 | 0.120 |
Why?
| | Stearic Acids | 1 | 2013 | 14 | 0.120 |
Why?
| | Polyethyleneimine | 1 | 2013 | 18 | 0.120 |
Why?
| | Myocardium | 1 | 2019 | 965 | 0.120 |
Why?
| | Phonophoresis | 1 | 2013 | 1 | 0.110 |
Why?
| | Heparin | 1 | 2014 | 230 | 0.110 |
Why?
| | Portal Vein | 1 | 2014 | 90 | 0.110 |
Why?
| | Microfluidic Analytical Techniques | 1 | 2013 | 75 | 0.110 |
Why?
| | Cells, Cultured | 7 | 2017 | 4044 | 0.110 |
Why?
| | Silicon Dioxide | 1 | 2013 | 95 | 0.110 |
Why?
| | Vena Cava, Superior | 2 | 2003 | 21 | 0.110 |
Why?
| | Herniorrhaphy | 1 | 2013 | 52 | 0.110 |
Why?
| | Tensile Strength | 1 | 2013 | 105 | 0.110 |
Why?
| | Microspheres | 2 | 2006 | 130 | 0.110 |
Why?
| | Industry | 1 | 2013 | 69 | 0.110 |
Why?
| | Cell Separation | 1 | 2013 | 293 | 0.110 |
Why?
| | Collagen | 2 | 2012 | 433 | 0.110 |
Why?
| | Tetraspanin 28 | 1 | 2012 | 4 | 0.110 |
Why?
| | Time Factors | 4 | 2015 | 6368 | 0.110 |
Why?
| | Intubation, Intratracheal | 1 | 2014 | 225 | 0.110 |
Why?
| | Neural Stem Cells | 1 | 2013 | 120 | 0.100 |
Why?
| | Coronary Vessels | 2 | 2004 | 233 | 0.100 |
Why?
| | Paclitaxel | 1 | 2013 | 193 | 0.100 |
Why?
| | Structure-Activity Relationship | 2 | 2013 | 522 | 0.100 |
Why?
| | Elastic Tissue | 1 | 2011 | 8 | 0.100 |
Why?
| | Sutures | 1 | 2012 | 61 | 0.100 |
Why?
| | Antineoplastic Agents, Phytogenic | 1 | 2013 | 180 | 0.100 |
Why?
| | Fibrillar Collagens | 1 | 2011 | 12 | 0.100 |
Why?
| | Ophthalmologic Surgical Procedures | 1 | 2012 | 60 | 0.100 |
Why?
| | Transfection | 1 | 2013 | 887 | 0.100 |
Why?
| | Diagnostic Imaging | 1 | 2014 | 294 | 0.100 |
Why?
| | Models, Animal | 1 | 2013 | 349 | 0.100 |
Why?
| | Predictive Value of Tests | 3 | 2015 | 1857 | 0.100 |
Why?
| | Oscillometry | 2 | 2013 | 33 | 0.100 |
Why?
| | Angiogenesis Inhibitors | 1 | 2013 | 218 | 0.100 |
Why?
| | Suture Techniques | 1 | 2012 | 134 | 0.100 |
Why?
| | Pressure | 3 | 2014 | 226 | 0.090 |
Why?
| | Swine | 1 | 2013 | 719 | 0.090 |
Why?
| | Arthroplasty | 1 | 2010 | 52 | 0.090 |
Why?
| | Intervertebral Disc Displacement | 1 | 2010 | 39 | 0.090 |
Why?
| | Equipment Failure | 1 | 2010 | 114 | 0.090 |
Why?
| | Species Specificity | 1 | 2011 | 559 | 0.090 |
Why?
| | Flow Cytometry | 1 | 2013 | 1072 | 0.090 |
Why?
| | Lipids | 1 | 2013 | 591 | 0.090 |
Why?
| | Cell Membrane | 1 | 2013 | 700 | 0.090 |
Why?
| | Central Venous Pressure | 1 | 2009 | 13 | 0.090 |
Why?
| | Nanoparticles | 1 | 2013 | 324 | 0.090 |
Why?
| | Coculture Techniques | 3 | 2019 | 206 | 0.090 |
Why?
| | Electric Capacitance | 1 | 2009 | 7 | 0.090 |
Why?
| | Viscosity | 1 | 2009 | 83 | 0.090 |
Why?
| | Mice | 8 | 2022 | 15446 | 0.090 |
Why?
| | Middle Aged | 4 | 2018 | 27514 | 0.090 |
Why?
| | Endothelial Growth Factors | 1 | 2009 | 54 | 0.090 |
Why?
| | Prostheses and Implants | 1 | 2010 | 142 | 0.090 |
Why?
| | Prosthesis Implantation | 1 | 2010 | 141 | 0.090 |
Why?
| | Echocardiography, Doppler, Color | 2 | 2000 | 38 | 0.090 |
Why?
| | Antibodies, Monoclonal, Humanized | 1 | 2013 | 665 | 0.090 |
Why?
| | Vasoconstrictor Agents | 1 | 2009 | 122 | 0.080 |
Why?
| | Hyperbaric Oxygenation | 1 | 2008 | 39 | 0.080 |
Why?
| | Stress, Physiological | 1 | 2012 | 414 | 0.080 |
Why?
| | Internship and Residency | 1 | 2018 | 1005 | 0.080 |
Why?
| | Prosthesis Design | 2 | 2007 | 285 | 0.080 |
Why?
| | Atherosclerosis | 1 | 2012 | 345 | 0.080 |
Why?
| | Cell Adhesion Molecules | 1 | 2009 | 177 | 0.080 |
Why?
| | Logistic Models | 2 | 2015 | 1896 | 0.080 |
Why?
| | Reference Standards | 1 | 2008 | 174 | 0.080 |
Why?
| | Tunica Media | 1 | 2007 | 35 | 0.080 |
Why?
| | Electric Impedance | 1 | 2007 | 99 | 0.070 |
Why?
| | Tunica Intima | 1 | 2007 | 77 | 0.070 |
Why?
| | Aortic Aneurysm, Abdominal | 1 | 2008 | 118 | 0.070 |
Why?
| | Signal Processing, Computer-Assisted | 1 | 2007 | 140 | 0.070 |
Why?
| | Probability | 1 | 2007 | 302 | 0.070 |
Why?
| | DNA | 1 | 2013 | 1385 | 0.070 |
Why?
| | Endothelium, Vascular | 2 | 2012 | 890 | 0.070 |
Why?
| | Blood Vessel Prosthesis | 1 | 2007 | 115 | 0.070 |
Why?
| | Cell Differentiation | 1 | 2013 | 1746 | 0.070 |
Why?
| | Prospective Studies | 1 | 2017 | 6443 | 0.070 |
Why?
| | Nanotubes | 1 | 2006 | 41 | 0.070 |
Why?
| | Hemolysis | 1 | 2006 | 171 | 0.070 |
Why?
| | Venae Cavae | 1 | 2005 | 10 | 0.070 |
Why?
| | Protein Conformation | 1 | 2008 | 848 | 0.070 |
Why?
| | Aortic Valve Stenosis | 2 | 1999 | 296 | 0.060 |
Why?
| | Adaptation, Physiological | 1 | 2008 | 501 | 0.060 |
Why?
| | Computing Methodologies | 1 | 2004 | 2 | 0.060 |
Why?
| | Manufactured Materials | 1 | 2004 | 5 | 0.060 |
Why?
| | Radiography | 1 | 2007 | 860 | 0.060 |
Why?
| | Anatomy, Cross-Sectional | 1 | 2004 | 12 | 0.060 |
Why?
| | ROC Curve | 2 | 2015 | 470 | 0.060 |
Why?
| | Surgery, Computer-Assisted | 1 | 2005 | 69 | 0.060 |
Why?
| | Research Design | 1 | 2010 | 961 | 0.060 |
Why?
| | Chronic Disease | 1 | 2010 | 1631 | 0.060 |
Why?
| | Rats, Long-Evans | 1 | 2004 | 105 | 0.060 |
Why?
| | Quality Control | 1 | 2004 | 155 | 0.060 |
Why?
| | Motion | 1 | 2004 | 95 | 0.060 |
Why?
| | Tomography, X-Ray Computed | 1 | 2013 | 2433 | 0.060 |
Why?
| | Mitral Valve | 1 | 2004 | 91 | 0.060 |
Why?
| | Dogs | 1 | 2004 | 369 | 0.050 |
Why?
| | Antineoplastic Agents | 1 | 2013 | 1968 | 0.050 |
Why?
| | Heart | 1 | 2006 | 630 | 0.050 |
Why?
| | Breast Neoplasms | 1 | 2013 | 1959 | 0.050 |
Why?
| | Pediatrics | 2 | 2006 | 980 | 0.050 |
Why?
| | RNA, Messenger | 1 | 2009 | 2657 | 0.050 |
Why?
| | Ultrasonography, Interventional | 1 | 2002 | 155 | 0.050 |
Why?
| | Cytokines | 1 | 2009 | 1880 | 0.050 |
Why?
| | Binomial Distribution | 1 | 2000 | 5 | 0.050 |
Why?
| | Retrospective Studies | 3 | 2015 | 12932 | 0.050 |
Why?
| | Risk Factors | 2 | 2015 | 8958 | 0.050 |
Why?
| | Interleukin-10 | 1 | 2022 | 304 | 0.050 |
Why?
| | Cell Survival | 2 | 2013 | 1045 | 0.050 |
Why?
| | Mechanotransduction, Cellular | 2 | 2012 | 100 | 0.050 |
Why?
| | Platelet-Derived Growth Factor | 1 | 2020 | 82 | 0.040 |
Why?
| | Myosin Heavy Chains | 2 | 2012 | 192 | 0.040 |
Why?
| | Human Umbilical Vein Endothelial Cells | 1 | 2020 | 94 | 0.040 |
Why?
| | Albumins | 1 | 1999 | 100 | 0.040 |
Why?
| | Actins | 2 | 2012 | 400 | 0.040 |
Why?
| | Injections, Subcutaneous | 1 | 2018 | 139 | 0.040 |
Why?
| | Formative Feedback | 1 | 2018 | 22 | 0.040 |
Why?
| | Cell Line | 2 | 2014 | 2693 | 0.040 |
Why?
| | Mitral Valve Stenosis | 1 | 1998 | 21 | 0.040 |
Why?
| | Prognosis | 2 | 2017 | 3425 | 0.040 |
Why?
| | Gelatin | 1 | 2017 | 36 | 0.040 |
Why?
| | Age Factors | 2 | 2015 | 2990 | 0.040 |
Why?
| | Young Adult | 3 | 2015 | 10731 | 0.030 |
Why?
| | Principal Component Analysis | 1 | 2015 | 179 | 0.030 |
Why?
| | Sulfonic Acids | 1 | 2014 | 13 | 0.030 |
Why?
| | Demography | 1 | 2015 | 273 | 0.030 |
Why?
| | Aging | 1 | 2005 | 1675 | 0.030 |
Why?
| | Proton Magnetic Resonance Spectroscopy | 1 | 2014 | 21 | 0.030 |
Why?
| | Phase Transition | 1 | 2014 | 29 | 0.030 |
Why?
| | Area Under Curve | 1 | 2015 | 293 | 0.030 |
Why?
| | Manikins | 1 | 2014 | 26 | 0.030 |
Why?
| | Constriction, Pathologic | 3 | 2000 | 204 | 0.030 |
Why?
| | Spectroscopy, Fourier Transform Infrared | 1 | 2014 | 86 | 0.030 |
Why?
| | Circular Dichroism | 1 | 2014 | 139 | 0.030 |
Why?
| | Static Electricity | 1 | 2014 | 120 | 0.030 |
Why?
| | Microscopy, Electron, Scanning | 1 | 2014 | 196 | 0.030 |
Why?
| | Cell Proliferation | 2 | 2013 | 2262 | 0.030 |
Why?
| | Patient Positioning | 1 | 2014 | 49 | 0.030 |
Why?
| | Cardiography, Impedance | 1 | 2013 | 6 | 0.030 |
Why?
| | Adhesiveness | 1 | 2013 | 19 | 0.030 |
Why?
| | Luciferases, Firefly | 1 | 2013 | 3 | 0.030 |
Why?
| | Myocardial Contraction | 1 | 2015 | 338 | 0.030 |
Why?
| | Head | 1 | 2014 | 86 | 0.030 |
Why?
| | Airway Management | 1 | 2014 | 63 | 0.030 |
Why?
| | Porosity | 1 | 2013 | 93 | 0.030 |
Why?
| | MCF-7 Cells | 1 | 2013 | 110 | 0.030 |
Why?
| | Trastuzumab | 1 | 2013 | 92 | 0.030 |
Why?
| | Adult | 3 | 2010 | 31328 | 0.030 |
Why?
| | Sonication | 1 | 2013 | 10 | 0.030 |
Why?
| | Drug Screening Assays, Antitumor | 1 | 2013 | 188 | 0.030 |
Why?
| | Ramipril | 1 | 2012 | 4 | 0.030 |
Why?
| | Cell Death | 1 | 2014 | 336 | 0.030 |
Why?
| | Quantum Dots | 1 | 2013 | 34 | 0.030 |
Why?
| | Survival Rate | 1 | 2017 | 1716 | 0.030 |
Why?
| | Peptidyl-Dipeptidase A | 1 | 2012 | 55 | 0.030 |
Why?
| | Hypertrophy | 1 | 2012 | 121 | 0.030 |
Why?
| | Plasmids | 1 | 2013 | 355 | 0.030 |
Why?
| | Drug Compounding | 1 | 2013 | 90 | 0.030 |
Why?
| | Treatment Outcome | 4 | 2013 | 9319 | 0.030 |
Why?
| | Methylphenazonium Methosulfate | 1 | 2012 | 1 | 0.030 |
Why?
| | Solubility | 1 | 2013 | 235 | 0.030 |
Why?
| | Surface Properties | 1 | 2013 | 397 | 0.030 |
Why?
| | Tumor Cells, Cultured | 1 | 2013 | 871 | 0.030 |
Why?
| | Liposomes | 1 | 2013 | 150 | 0.030 |
Why?
| | Hyaluronic Acid | 1 | 2013 | 196 | 0.030 |
Why?
| | Transforming Growth Factor beta1 | 1 | 2012 | 162 | 0.030 |
Why?
| | Clinical Competence | 1 | 2018 | 950 | 0.020 |
Why?
| | Microcirculation | 1 | 2012 | 152 | 0.020 |
Why?
| | Statistics, Nonparametric | 1 | 2012 | 400 | 0.020 |
Why?
| | Immunohistochemistry | 1 | 2014 | 1681 | 0.020 |
Why?
| | Xenograft Model Antitumor Assays | 1 | 2013 | 737 | 0.020 |
Why?
| | Vasodilation | 1 | 2013 | 456 | 0.020 |
Why?
| | Mice, Inbred BALB C | 1 | 2013 | 1202 | 0.020 |
Why?
| | Thromboxane B2 | 1 | 2009 | 27 | 0.020 |
Why?
| | Prostaglandins F | 1 | 2009 | 18 | 0.020 |
Why?
| | Hypoxanthine Phosphoribosyltransferase | 1 | 2009 | 26 | 0.020 |
Why?
| | Software | 1 | 2013 | 566 | 0.020 |
Why?
| | E-Selectin | 1 | 2009 | 51 | 0.020 |
Why?
| | Sulfonamides | 1 | 2012 | 444 | 0.020 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2013 | 1937 | 0.020 |
Why?
| | Blotting, Western | 1 | 2012 | 1186 | 0.020 |
Why?
| | Inflammation | 1 | 2020 | 2545 | 0.020 |
Why?
| | Chemokine CCL2 | 1 | 2009 | 124 | 0.020 |
Why?
| | Mice, Inbred C57BL | 1 | 2018 | 4887 | 0.020 |
Why?
| | Polyethylene Glycols | 1 | 2013 | 575 | 0.020 |
Why?
| | Nitric Oxide Synthase Type III | 1 | 2009 | 198 | 0.020 |
Why?
| | Cadherins | 1 | 2009 | 186 | 0.020 |
Why?
| | Endothelin-1 | 1 | 2009 | 167 | 0.020 |
Why?
| | Extracellular Matrix | 1 | 2011 | 444 | 0.020 |
Why?
| | Transcriptional Activation | 1 | 2009 | 347 | 0.020 |
Why?
| | Acrylates | 1 | 2007 | 47 | 0.020 |
Why?
| | Proto-Oncogene Proteins c-akt | 1 | 2009 | 418 | 0.020 |
Why?
| | Antigens, CD | 1 | 2009 | 457 | 0.020 |
Why?
| | Analysis of Variance | 1 | 2009 | 1288 | 0.020 |
Why?
| | Cell Line, Tumor | 1 | 2013 | 2837 | 0.020 |
Why?
| | Up-Regulation | 1 | 2009 | 862 | 0.020 |
Why?
| | Phosphorylation | 1 | 2009 | 1622 | 0.020 |
Why?
| | Disease Progression | 1 | 2012 | 2477 | 0.020 |
Why?
| | Nitric Oxide | 1 | 2009 | 891 | 0.010 |
Why?
| | Gene Expression | 1 | 2009 | 1482 | 0.010 |
Why?
| | Apoptosis | 1 | 2013 | 2461 | 0.010 |
Why?
| | Stents | 1 | 2007 | 457 | 0.010 |
Why?
| | Regression Analysis | 1 | 2005 | 984 | 0.010 |
Why?
| | Monitoring, Intraoperative | 1 | 2002 | 43 | 0.010 |
Why?
| | Anastomosis, Surgical | 1 | 2002 | 146 | 0.010 |
Why?
| | Angioplasty, Balloon | 1 | 1999 | 88 | 0.010 |
Why?
| | Veins | 1 | 1998 | 59 | 0.010 |
Why?
| | Cohort Studies | 1 | 2005 | 5078 | 0.010 |
Why?
| | Postoperative Complications | 1 | 2002 | 2230 | 0.010 |
Why?
| | Aged | 1 | 2005 | 19599 | 0.000 |
Why?
|
|
Shandas's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|